Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment-Reference-Cited by-同舟云学术

Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment

Published:2012-09-14 Issue:20 Volume:11 Page:3837-3850
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Oplustilova Lenka¹²,Wolanin Kamila¹,Mistrik Martin³,Korinkova Gabriela³,Simkova Dana³,Bouchal Jan³,Lenobel Rene⁴,Bartkova Jirina¹,Lau Alan²,O’Connor Mark J.²,Lukas Jiri¹⁵,Bartek Jiri¹³

Affiliation:

1. Danish Cancer Society Research Center; Copenhagen, Denmark

2. AstraZeneca; iMed Oncology; Macclesfield, Cheshire, UK

3. Institute of Molecular and Translational Medicine; Faculty of Medicine and Dentistry; Palacky University; Olomouc, Czech Republic

4. Laboratory of Growth Regulators; Palacky University Olomouc; Olomouc, Czech Republic

5. Novo Nordisk Foundation Center for Protein Research; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen, Denmark

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.4161/cc.22026

Reference53 articles.

1. Targeted cancer therapies based on the inhibition of DNA strand break repair;O’Connor;Oncogene,2007

2. The DNA damage response and cancer therapy;Lord;Nature,2012

3. The DNA-damage response in human biology and disease;Jackson;Nature,2009

4. NCI’s provocative questions on cancer: some answers to ignite discussion;Blagosklonny;Oncotarget,2011

5. Poly(ADP-ribose): novel functions for an old molecule;Schreiber;Nat Rev Mol Cell Biol,2006

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex;British Journal of Cancer;2024-06-12

2. Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids;Cell & Bioscience;2024-02-06

3. Unravelling the molecular basis of PARP inhibitor resistance in prostate cancer with homologous recombination repair deficiency;International Review of Cell and Molecular Biology;2024

4. Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?;Cancer Treatment Reviews;2023-12

5. An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time;Cell Reports Medicine;2023-11